Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Aug 4;4(3):155–167. doi: 10.1093/pcmedi/pbab020

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021. Published by Oxford University Press on behalf of the West China School of Medicine & West China Hospital of Sichuan University.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 4. — The antitumor activity of CXCL13 was mediated by both innate immunity and adaptive immunity. (A) BALB/cA-nu nude mice were injected in the right dorsal flank with 2 × 10⁵ 4T1, 4T1-pCDH, 4T1-CXCL13-1, or 4T1-CXCL13-2 cells. Bars, means ± SD (n = 10). (B) In BALB/c and BALB/cA-nu experiments, the ratios of average tumor volume between 4T1-CXCL13 and 4T1 groups were shown on day 32 after tumor inoculation, respectively (***P < 0.001). (C) 4T1 tumor growth in the bilateral tumor inoculation of BALB/c mice. Each curve stands for the 4T1 tumor growth of one mouse (n = 8). (D) Statistic results of 4T1 tumor volume on days 13, 22, and 31 after bilateral tumor inoculations (*P < 0.05, **P < 0.01).